Skip to content
TrialScanner

NCT04995653

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Phase 1CompletedMCRBLead

Registry record

Lead sponsor
Seres Therapeutics, Inc.
Conditions
Allogeneic Hematopoietic Stem Cell Transplantation
Primary completion
Jul 23, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04995653 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04995653: A Multiple Dose Study to... | TrialScanner